3.8 Article

Familial dysautonomia:: Detection of the IKBKA-P IVS20+6T→C and R696P mutations and frequencies among Ashkenazi Jews

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS
Volume 110, Issue 3, Pages 253-257

Publisher

WILEY-LISS
DOI: 10.1002/ajmg.10450

Keywords

allele-specific oligonucleotide hybridization; IKBKAP; familial dysautonomia; Ashkenazi Jewish population

Funding

  1. NCRR NIH HHS [5 M01 RR00071] Funding Source: Medline
  2. NICHD NIH HHS [5 P30 HD28822] Funding Source: Medline
  3. NIDDK NIH HHS [5 R37 DK34045] Funding Source: Medline

Ask authors/readers for more resources

Familial dysautonomia (FD) is an autosomal recessive congenital neuropathy that occurs almost exclusively in the Ashkenazi Jewish (AJ) population. Mutations in the IkappaB kinase complex-associated protein (IKBKAP) gene cause FD. Two IKBKAP mutations, IVS20(+6T --> C) and R696P, have been identified in FD patients of AJ descent. The (6T --> C) splice site mutation IVS20(+) is responsible for > 99.5% of known AJ patients with FD, and haplotype analyses were consistent with a common founder. In contrast, the R696P mutation has been identified in only a few AJ patients. To facilitate carrier detection, a single PCR and allele-specific oligonucleotide (ASO) hybridization assay was developed to facilitate the detection of both the IVS20(+6T --> C) and R696P mutations. Screening of 2,518 anonymous AJ individuals from the New York metropolitan area revealed a carrier frequency for IVS20(+6T) (--> C) of 1 in 32 (3.2%; 95% CI, 2.5-3.9%), similar to the previously estimated carrier frequency (3.3%) based on disease incidence. No carrier was identified for the R696P lesion, indicating that the mutation was rare in this population (< 1 in 2,500). This sensitive and specific assay should facilitate carrier screening for FD mutations in the AJ community, as well as postnatal diagnostic testing. (C) 2002 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available